CytoSNP-850K (8-sample)

CytoSNP-850K (8-sample)

The Infinium CytoSNP-850K BeadChip provides the most comprehensive coverage of cytogenomic-relevant genes for studies associated with congenital disorders and cancer. The gene list for the CytoSNP-850K BeadChip was defined based on content from the International Collaboration for Clinical Genomics (ICCG) (formerly known as the International Standard of Cytogenomics Array (ISCA) consortium), the Cancer Cytogenetics Microarray Consortium (CCMC), and Sanger, providing a comprehensive view of cytogenomic activity. It is the first SNP-based human microarray to leverage the latest input from the international community for constitutional and cancer applications.
The CytoSNP-850K BeadChip contains approximately 850,000 empirically selected single nucleotide polymorphisms (SNPs) spanning the entire genome with enriched coverage for 3,262 genes of known cytogenetics relevance in both constitutional and cancer applications. The processed arrays can be scanned using the iScan, HiScan, or NextSeq 550 systems with high reproducibility.

Order Now Support Training

Please rotate your device for details

Specifications
Number of Fixed Markers

iScan/HiScan - 843,888

NextSeq 550 - 844,049
Available Custom Markers, max. N/A
Number of Samples 8
DNA Requirement 200 ng
Assay Infinium HD Super
FFPE compatible Yes

Product and Ordering Information

  • CytoSNP-850K v1.1 DNA Analysis BeadChip Kits: WG-322-1101 (8 samples), WG-322-1102 (16 samples), WG-322-1103 (48 samples), WG-322-1104 (96 samples)
  • CytoSNP-850K Product Page

Support Links

Order Now Support Training
For Research Use Only

Not for use in diagnostic procedures (except as specifically noted).

Innovative technologies

At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.

All trademarks are the property of Illumina, Inc. or their respective owners.
For specific trademark information, see emea.illumina.com/company/legal.html.

© 2026 Illumina, Inc. All rights reserved.